文献速递神经儿科影像MR

儿童急性中毒性白质脑病:不同病因下FLAIR与DWI对临床结局的预测

Pediatric Acute Toxic Leukoencephalopathy: Prediction of the Clinical Outcome by FLAIR and DWI for Various Etiologies.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-07-02

该研究回顾性分析19例儿童急性中毒性白质脑病患者的MRI资料,由两名神经放射科医生对DWI和FLAIR严重程度评分并测量ADC下降百分比,采用Spearman相关分析与临床结局的相关性。结果显示DWI和FLAIR严重程度评分与临床结局高度相关,ADC下降百分比呈中度相关;接受氟达拉滨治疗的患者结局最差,免疫抑制相关者倾向于良好结局。

要点

  • DWI与FLAIR严重程度评分与儿童急性中毒性白质脑病临床结局高度相关。
  • ADC下降百分比与临床结局呈中度相关,高下降值关联不良结局。
  • 氟达拉滨相关者结局最差,免疫抑制相关者倾向于良好结局。

核心结论

  • DWI和FLAIR严重程度评分对儿童急性中毒性白质脑病临床结局似乎具有高度预后价值。
  • ADC下降百分比对该病的临床结局具有中度预后价值。
  • 免疫抑制相关儿童急性中毒性白质脑病倾向于良好结局,氟达拉滨倾向于更差结局。

研究设计与样本

  • 回顾性研究,纳入19例年龄小于19岁的儿童急性中毒性白质脑病患儿,均在就诊后2周内完成包含DWI和FLAIR序列的MR检查。
  • 由两名神经放射科医生对DWI和FLAIR严重程度进行评分,并测量可见受累区域及表现正常白质内的ADC下降百分比。
  • 采用Spearman相关分析评估ADC下降百分比及DWI、FLAIR严重程度与临床结局的相关性。
  • 病因构成:甲氨蝶呤6例、骨髓移植4例、氟达拉滨3例、阿糖胞苷1例、卡铂1例、长春新碱1例、环孢素1例、尿毒症1例、贝伐珠单抗1例。
  • 分为三个亚组分析:化疗组12例、免疫抑制组5例、其他组2例。

关键影像表现/征象

  • DWI和FLAIR上可见白质病变,并据此进行严重程度评分。
  • 在可见受累区域及表现正常白质内测量ADC下降百分比。

诊断标准与关键数值

  • FLAIR严重程度与临床结局强相关(r=0.773,P<.001)。
  • DWI严重程度与临床结局强相关(r=0.851,P<.001)。
  • ADC下降百分比与临床结局中度相关(r=0.570,P=.011),高ADC下降值关联不良结局,低ADC下降值关联良好结局。

临床应用与阅片要点

  • 对儿童急性中毒性白质脑病,可结合DWI和FLAIR严重程度评分评估临床结局。
  • ADC下降百分比可作为辅助预后指标,其预后价值为中度。
  • 氟达拉滨相关者提示结局较差,免疫抑制相关者倾向于良好结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Pediatric acute toxic leukoencephalopathy is a clinicoradiologic entity comprising various etiologies. This study aimed to identify the MR imaging appearance of pediatric acute toxic leukoencephalopathy from various etiologies and determine whether the etiology correlates with clinical outcome.

MATERIALS AND METHODS: We retrospectively reviewed the electronic records of patients with pediatric acute toxic leukoencephalopathy younger than 19 years of age who had MR imaging within <2 weeks of presentation, including DWI and FLAIR sequences. Two neuroradiologists scored the DWI and FLAIR severity and measured the percentage ADC reduction within the visibly affected regions and normal-appearing WM. The percentage ADC reduction and DWI and FLAIR severity were correlated with clinical outcome using the Spearman correlation.

RESULTS: Of 22 children, 3 were excluded due to a nontoxic cause or incomplete examination. Regarding the included 19 children (mean age, 13 years), the etiologies of pediatric acute toxic leukoencephalopathy were the following: methotrexate (n = 6), bone marrow transplantation (n = 4), fludarabine (n = 3), cytarabine (n = 1), carboplatin (n = 1), vincristine (n = 1), cyclosporine (n = 1), uremia (n = 1), and bevacizumab (n = 1). Three subgroups were analyzed (chemotherapy, n = 12; immunosuppression, n = 5; others, n = 2). There was a strong correlation of FLAIR (r = 0.773, P < .001) and DWI (r = 0.851, P < .001) severity with clinical outcome, and patients treated with fludarabine had the worst outcomes. High percentage ADC reduction values were associated with adverse outcomes, and lower percentage ADC reduction values were associated with favorable outcomes (r = 0.570, P = .011).

CONCLUSIONS: The DWI and FLAIR severity scores appear highly prognostic, whereas percentage ADC reduction is moderately prognostic for clinical outcomes in pediatric acute toxic leukoencephalopathy. Immunosuppressive pediatric acute toxic leukoencephalopathy tends toward favorable outcomes, and fludarabine tends toward worse outcomes.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Ozturk K, Rykken J, McKinney AM, et al. Pediatric Acute Toxic Leukoencephalopathy: Prediction of the Clinical Outcome by FLAIR and DWI for Various Etiologies. AJNR Am J Neuroradiol. 2020. PMID: 32616577. doi:10.3174/ajnr.A6624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。